Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

600267.SS Gross Margin

The Gross Margin of Zhejiang Hisun Pharmaceutical Co Ltd (600267.SS) is 43.80%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

600267.SS Gross Margin - Historical Value
Date Value
2024-12-31 43.80%
2023-12-31 39.20%
2022-12-31 41.05%
2021-12-31 39.90%
2020-12-31 42.61%
2019-12-31 40.05%
2018-12-31 41.06%
2017-12-31 30.86%
2016-12-31 26.90%
2015-12-31 27.48%
600267.SS Gross Margin - Peers Comparison
Ticker Name Value
1666.HK Tong Ren Tang Technologies Co Ltd 39.64%
2096.HK Simcere Pharmaceutical Group Ltd 80.25%
600812.SS North China Pharmaceutical Co Ltd 31.84%
000756.SZ Shandong Xinhua Pharmaceutical Co Ltd 23.50%
002603.SZ Shijiazhuang Yiling Pharmaceutical Co Ltd 57.03%
600422.SS KPC Pharmaceuticals Inc 43.22%
000513.SZ Livzon Pharmaceutical Group Inc 64.80%
002755.SZ Beijing Aosaikang Pharmaceutical Co Ltd 80.77%
600664.SS Harbin Pharmaceutical Group Co Ltd 26.02%
600329.SS Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd 43.66%
600566.SS Hubei Jumpcan Pharmaceutical Co Ltd 81.52%
2186.HK Luye Pharma Group Ltd 66.72%
600085.SS Beijing Tongrentang Co Ltd 46.62%
600572.SS Zhejiang CONBA Pharmaceutical Co Ltd 57.88%
603858.SS Shandong Buchang Pharmaceuticals Co Ltd 67.80%
000999.SZ China Resources Sanjiu Medical & Pharmaceutical Co Ltd 51.36%
002019.SZ Yifan Pharmaceutical Co Ltd 47.42%
300026.SZ Tianjin Chase Sun Pharmaceutical Co Ltd 53.88%
600216.SS Zhejiang Medicine Co Ltd 30.95%
000739.SZ Apeloa Pharmaceutical Co Ltd 23.26%
600129.SS Chongqing Taiji Industry Group Co Ltd 38.97%
600518.SS Kangmei Pharmaceutical Co Ltd 22.22%
000597.SZ Northeast Pharmaceutical Group Co Ltd 37.28%
002390.SZ Guizhou Xinbang Pharmaceutical Co Ltd 18.90%
002793.SZ Luoxin Pharmaceuticals Group Stock Co Ltd 43.33%
600062.SS China Resources Double-Crane Pharmaceutical Co Ltd 57.05%
600380.SS Joincare Pharmaceutical Group Industry Co Ltd 62.13%
600420.SS Shanghai Shyndec Pharmaceutical Co Ltd 37.94%